-
Allianz CIO Utermann: Deutsche Bank Is 'Too Important,' Says State Support Will Be Available
Monday, September 26, 2016 - 10:25am | 340Read More...According to a Bloomberg report, Deutsche Bank AG (USA) (NYSE: DB) could be forced to raise capital in order to pay a $14 billion fee imposed by the U.S. Department of Justice. Shares of the German bank fell to a new-all time low early Monday morning following the report that also suggested the...
-
Allianz's Analyst Likes Biogen Idec Inc, Celgene Corporation & Gilead
Saturday, September 6, 2014 - 5:28pm | 209Read More...John Schroer of Allianz Global Investors spoke on CNBC's Fast Money about the biotech stocks he likes. He said that his first pick would be Biogen Idec Inc (NASDAQ: BIIB), which is a leading company in the multiple sclerosis space. He thinks that the company will have 20 to 25 percent...
